The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease

Accumulated evidence suggests that an altered ambulatory blood pressure (BP) profile, particularly elevated nighttime BP, reflects target organ injury and is a better predictor of further cardiorenal risk than the clinic BP or daytime BP in hypertensive patients complicated by chronic kidney disease...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Yanagi, Mai, Tamura, Kouichi, Fujikawa, Tetsuya, Wakui, Hiromichi, Kanaoka, Tomohiko, Ohsawa, Masato, Azushima, Kengo, Maeda, Akinobu, Kobori, Hiroyuki, Umemura, Satoshi
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3594468/
https://ncbi.nlm.nih.gov/pubmed/23154587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/hr.2012.184
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki